Trastuzumab deruxtecan

AbMole BioScience

Trastuzumab deruxtecan

9

1826843-81-5

Chemical

Research Use Only

Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, and a topoisomerase I inhibitor. Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer.

Please store the product under the recommended conditions in the Certificate of Analysis.

12352200